Showing results (21-30 of 32) with videos related to

Sort By:
Pageof 4
Cancer Research Communications|June 28, 2023
Targeting CHAF1B Enhances IFN Activity against Myeloproliferative Neoplasm CellsDiana Saleiro, Ewa M Kosciuczuk, Mariafausta Fischietti, et al.
Oncotarget|January 7, 2020
Inhibitory effects of SEL201 in acute myeloid leukemiaEwa M Kosciuczuk, Aroop K Kar, Gavin T Blyth, et al.
Cancer Research Communications|November 16, 2022
SLFN11 negatively regulates non-canonical NFkB signaling to promote glioblastoma progressionMariafausta Fischietti, Frank Eckerdt, Ricardo E Perez, et al.
Cancer Immunology Research|September 19, 2019
Myeloid-Derived Suppressive Cells Promote B cell-Mediated Immunosuppression via Transfer of PD-L1 in GlioblastomaCatalina Lee-Chang, Aida Rashidi, Jason Miska, et al.
Cancer Research|December 28, 2017
GADD45β Loss Ablates Innate Immunosuppression in CancerDaniela Verzella, Jason Bennett, Mariafausta Fischietti, et al.
Blood|December 28, 2018
Identification and targeting of novel CDK9 complexes in acute myeloid leukemiaElspeth M Beauchamp, Sameem M Abedin, Sara G Radecki, et al.
JCI Insight|January 27, 2026
Schlafen 5 is an intracellular immune checkpoint and controls interferon responses in pancreatic ductal adenocarcinomaMariafausta Fischietti, Markella Zannikou, Elspeth M Beauchamp, et al.
Oncogene|April 13, 2021
Schlafen 5 as a novel therapeutic target in pancreatic ductal adenocarcinomaMariafausta Fischietti, Frank Eckerdt, Gavin T Blyth, et al.
Nature Communications|April 2, 2022
Discovery of a signaling feedback circuit that defines interferon responses in myeloproliferative neoplasmsDiana Saleiro, Jeremy Q Wen, Ewa M Kosciuczuk, et al.
Molecular Cancer Therapeutics|December 21, 2025
Development of a SIN1 targeting inhibitor as a novel therapeutic approach for the treatment of malignanciesElspeth M Beauchamp, Atul Jain, Matt Clutter, et al.
Pageof 4